Kiniksa Pharmaceuticals International Plc (KNSA)
48.13
-0.02
(-0.04%)
USD |
NASDAQ |
Apr 01, 16:00
48.13
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Research and Development Expense (TTM) : 96.66M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NovoCure Ltd. | 224.54M |
| Marker Therapeutics, Inc. | 11.80M |
| LivaNova Plc | 185.14M |
| Aurinia Pharmaceuticals, Inc. | 32.50M |
| Alterola Biotech, Inc. | -- |